Cancer Head lines
Vaccine Boosts Survival for Men With Advanced Prostate Cancer:
Study
(HealthDay)
HealthDay - WEDNESDAY, July 28 (HealthDay News) -- A newly approved therapeutic prostate cancer vaccine extended the lives of men with metastatic tumors resistant to standard hormonal treatment, a new study shows.
Pubished :Thu, 29 Jul 2010 03:47:24 GMT
HealthDay - WEDNESDAY, July 28 (HealthDay News) -- A newly approved therapeutic prostate cancer vaccine extended the lives of men with metastatic tumors resistant to standard hormonal treatment, a new study shows.
Pubished :Thu, 29 Jul 2010 03:47:24 GMT
Prostate Cancer 'Cell of Origin' Identified
(LiveScience.com)
LiveScience.com - For researchers, a key to studying any cancer is finding its "cell of origin." Now scientists at the University of California at Los Angeles say they've found just that -- a specific type of cell that gives rise to prostate cancer.
Pubished :Thu, 29 Jul 2010 21:10:30 GMT
LiveScience.com - For researchers, a key to studying any cancer is finding its "cell of origin." Now scientists at the University of California at Los Angeles say they've found just that -- a specific type of cell that gives rise to prostate cancer.
Pubished :Thu, 29 Jul 2010 21:10:30 GMT
Court ruling could pave way for Gemzar generics
(Reuters)
Reuters - A decision by a U.S. appeals court could pave the way for cheaper generic forms of Eli Lilly and Co's Gemzar cancer drug to be launched in the United States beginning in mid-November.
Pubished :Thu, 29 Jul 2010 03:52:03 GMT
Reuters - A decision by a U.S. appeals court could pave the way for cheaper generic forms of Eli Lilly and Co's Gemzar cancer drug to be launched in the United States beginning in mid-November.
Pubished :Thu, 29 Jul 2010 03:52:03 GMT
Test designed to screen resistance to cancer drug
(Reuters)
Reuters - Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the standard drug for treating leukemia or cancer of the blood cells.
Pubished :Thu, 29 Jul 2010 04:17:51 GMT
Reuters - Researchers in Japan have designed a test to identify patients who are likely to be resistant to imatinib, the standard drug for treating leukemia or cancer of the blood cells.
Pubished :Thu, 29 Jul 2010 04:17:51 GMT
Technology May Explain Mammogram's Poorer Performance in Younger
Women
(HealthDay)
HealthDay - TUESDAY, July 27 (HealthDay News) -- The poorer tumor detection rate offered by mammography for women in their 40s is due more to the technology itself than characteristics of a younger woman's cancer, according to a new study.
Pubished :Wed, 28 Jul 2010 03:48:47 GMT
HealthDay - TUESDAY, July 27 (HealthDay News) -- The poorer tumor detection rate offered by mammography for women in their 40s is due more to the technology itself than characteristics of a younger woman's cancer, according to a new study.
Pubished :Wed, 28 Jul 2010 03:48:47 GMT
Researchers Identify Gene Variants for Breast Cancer
(Time.com)
Time.com - Some genes may not help researchers predict who will develop cancer, but it may help them treat tumors more effectively
Pubished :Tue, 27 Jul 2010 14:25:00 GMT
Time.com - Some genes may not help researchers predict who will develop cancer, but it may help them treat tumors more effectively
Pubished :Tue, 27 Jul 2010 14:25:00 GMT
Genetic Risk Score Can Predict Odds For Breast Cancer
(HealthDay)
HealthDay - TUESDAY, July 27 (HealthDay News) -- Taking advantage of recent discoveries of more genetic variants that raise the risk for breast cancer, European scientists have analyzed those variants in relation to breast cancer and found that the risk is greater with certain variants and for certain tumor types.
Pubished :Tue, 27 Jul 2010 21:02:41 GMT
HealthDay - TUESDAY, July 27 (HealthDay News) -- Taking advantage of recent discoveries of more genetic variants that raise the risk for breast cancer, European scientists have analyzed those variants in relation to breast cancer and found that the risk is greater with certain variants and for certain tumor types.
Pubished :Tue, 27 Jul 2010 21:02:41 GMT
UK finds extra 50 million pounds for cancer drugs
(Reuters)
Reuters - Britain is providing an extra 50 million pounds ($78 million) to pay for cancer medicines from October, bringing forward a government promise to give access to drugs even if they have not been approved by cost watchdog NICE.
Pubished :Tue, 27 Jul 2010 15:34:33 GMT
Reuters - Britain is providing an extra 50 million pounds ($78 million) to pay for cancer medicines from October, bringing forward a government promise to give access to drugs even if they have not been approved by cost watchdog NICE.
Pubished :Tue, 27 Jul 2010 15:34:33 GMT
Low-risk prostate cancer treated aggressively
(Reuters)
Reuters - Many men with low-risk prostate cancer get aggressive treatment, increasing the risk of serious side effects, U.S. researchers said on Monday.
Pubished :Mon, 26 Jul 2010 20:04:43 GMT
Reuters - Many men with low-risk prostate cancer get aggressive treatment, increasing the risk of serious side effects, U.S. researchers said on Monday.
Pubished :Mon, 26 Jul 2010 20:04:43 GMT
Most Men With Low-Risk Prostate Cancer Treated Aggressively, Study
Shows
(HealthDay)
HealthDay - MONDAY, July 26 (HealthDay News) -- Too many men with low-risk prostate cancers, those whose level of prostate-specific antigen (PSA) is normal or below normal, still receive aggressive treatment, a new study shows.
Pubished :Mon, 26 Jul 2010 21:03:44 GMT
HealthDay - MONDAY, July 26 (HealthDay News) -- Too many men with low-risk prostate cancers, those whose level of prostate-specific antigen (PSA) is normal or below normal, still receive aggressive treatment, a new study shows.
Pubished :Mon, 26 Jul 2010 21:03:44 GMT
Duke scientist's cancer research is questioned
(AP)
AP - Concerns are being raised about the validity of research done by a Duke University cancer scientist who recently was placed on leave while the school investigates whether he falsely claimed to be a Rhodes scholar.
Pubished :Fri, 23 Jul 2010 21:27:16 GMT
AP - Concerns are being raised about the validity of research done by a Duke University cancer scientist who recently was placed on leave while the school investigates whether he falsely claimed to be a Rhodes scholar.
Pubished :Fri, 23 Jul 2010 21:27:16 GMT
Women of African Heritage May Face Greater Aggressive Breast Cancer
Risk
(HealthDay)
HealthDay - FRIDAY, July 23 (HealthDay News) -- Women of African heritage bear a greater risk for a more aggressive and difficult-to-treat form of breast cancer, new research suggests.
Pubished :Fri, 23 Jul 2010 21:03:01 GMT
HealthDay - FRIDAY, July 23 (HealthDay News) -- Women of African heritage bear a greater risk for a more aggressive and difficult-to-treat form of breast cancer, new research suggests.
Pubished :Fri, 23 Jul 2010 21:03:01 GMT
FDA staff: Cancer a concern with Medtronic device
(Reuters)
Reuters - U.S. reviewers are concerned about cancer cases in some patients implanted with an experimental Medtronic Inc device developed to treat lower back pain, according to documents released on Friday.
Pubished :Fri, 23 Jul 2010 19:39:04 GMT
Reuters - U.S. reviewers are concerned about cancer cases in some patients implanted with an experimental Medtronic Inc device developed to treat lower back pain, according to documents released on Friday.
Pubished :Fri, 23 Jul 2010 19:39:04 GMT
Cancer a concern with Medtronic device: FDA
(Reuters)
Reuters - U.S. reviewers are concerned about cancer cases seen in patients treated with an experimental Medtronic Inc spinal fusion device, documents released on Friday said.
Pubished :Fri, 23 Jul 2010 14:49:12 GMT
Reuters - U.S. reviewers are concerned about cancer cases seen in patients treated with an experimental Medtronic Inc spinal fusion device, documents released on Friday said.
Pubished :Fri, 23 Jul 2010 14:49:12 GMT
Cancer Docs 'Frustrated' By Lack of Useful Info in Journal
Articles
(HealthDay)
HealthDay - THURSDAY, July 22 (HealthDay News) -- Medical journals should include more clinical details in cancer research studies to help doctors better understand and utilize results, according to U.S. researchers.
Pubished :Thu, 22 Jul 2010 21:04:07 GMT
HealthDay - THURSDAY, July 22 (HealthDay News) -- Medical journals should include more clinical details in cancer research studies to help doctors better understand and utilize results, according to U.S. researchers.
Pubished :Thu, 22 Jul 2010 21:04:07 GMT
Benefit confirmed in "bubble boy" treatment
(Reuters)
Reuters - A 10-year study of nine boys born without the ability to ward off germs has found that gene therapy is an effective long-term treatment, but it carries a price: four of them developed leukemia.
Pubished :Wed, 21 Jul 2010 21:03:42 GMT
Reuters - A 10-year study of nine boys born without the ability to ward off germs has found that gene therapy is an effective long-term treatment, but it carries a price: four of them developed leukemia.
Pubished :Wed, 21 Jul 2010 21:03:42 GMT
Florida's Minorities See Unusual Melanoma Patterns
(HealthDay)
HealthDay - WEDNESDAY, July 21 (HealthDay News) -- Melanoma trends among minority groups in Florida, the Sunshine State, are different than national trends, a new study finds.
Pubished :Wed, 21 Jul 2010 21:02:45 GMT
HealthDay - WEDNESDAY, July 21 (HealthDay News) -- Melanoma trends among minority groups in Florida, the Sunshine State, are different than national trends, a new study finds.
Pubished :Wed, 21 Jul 2010 21:02:45 GMT
No link seen between coffee, prostate cancer risk
(Reuters)
Reuters - Men who enjoy their morning cup of coffee can drink a little easier. A new research review finds that java lovers appear no more likely to develop prostate cancer than other men.
Pubished :Wed, 21 Jul 2010 17:18:32 GMT
Reuters - Men who enjoy their morning cup of coffee can drink a little easier. A new research review finds that java lovers appear no more likely to develop prostate cancer than other men.
Pubished :Wed, 21 Jul 2010 17:18:32 GMT
Experts veto Avastin as a breast cancer treatment
(AP)
AP - A panel of cancer experts said Tuesday that the government should remove its endorsement of Roche's drug Avastin for breast cancer, after follow-up studies failed to show benefits for patients.
Pubished :Tue, 20 Jul 2010 21:28:37 GMT
AP - A panel of cancer experts said Tuesday that the government should remove its endorsement of Roche's drug Avastin for breast cancer, after follow-up studies failed to show benefits for patients.
Pubished :Tue, 20 Jul 2010 21:28:37 GMT
Darker skin doesn't mean melanoma immunity
(Reuters)
Reuters - Melanoma is on the rise among certain groups of dark-skinned Floridians, new research shows.
Pubished :Tue, 20 Jul 2010 21:15:59 GMT
Reuters - Melanoma is on the rise among certain groups of dark-skinned Floridians, new research shows.
Pubished :Tue, 20 Jul 2010 21:15:59 GMT
Study Suggests Painters Face Increased Risk of Bladder
Cancer
(HealthDay)
HealthDay - TUESDAY, July 20 (HealthDay News) -- Professional painters may face an increased risk for bladder cancer and that risk seems to rise with the number of years they work, a new study suggests.
Pubished :Tue, 20 Jul 2010 21:02:25 GMT
HealthDay - TUESDAY, July 20 (HealthDay News) -- Professional painters may face an increased risk for bladder cancer and that risk seems to rise with the number of years they work, a new study suggests.
Pubished :Tue, 20 Jul 2010 21:02:25 GMT
Avastin Largely Safe for Patients With Type of Advanced Lung
Cancer
(HealthDay)
HealthDay - TUESDAY, July 20 (HealthDay News) -- The cancer drug Avastin, when used in combination with standard chemotherapy, is safe and can effectively treat an advanced form of one of the most common lung cancers, researchers report.
Pubished :Tue, 20 Jul 2010 21:02:21 GMT
HealthDay - TUESDAY, July 20 (HealthDay News) -- The cancer drug Avastin, when used in combination with standard chemotherapy, is safe and can effectively treat an advanced form of one of the most common lung cancers, researchers report.
Pubished :Tue, 20 Jul 2010 21:02:21 GMT
Cigarette Smoke May Up Cancer Risk By Interfering With
Genes
(HealthDay)
HealthDay - MONDAY, July 19 (HealthDay News) -- Exposure to cigarette smoke can undermine the immune system and raise the risk for cancer, cell death and metabolic problems by harming gene expression, new research reveals.
Pubished :Mon, 19 Jul 2010 21:03:17 GMT
HealthDay - MONDAY, July 19 (HealthDay News) -- Exposure to cigarette smoke can undermine the immune system and raise the risk for cancer, cell death and metabolic problems by harming gene expression, new research reveals.
Pubished :Mon, 19 Jul 2010 21:03:17 GMT
Health, Money Woes May Boost Bowel Cancer Deaths in Blacks
(HealthDay)
HealthDay - FRIDAY, July 16 (HealthDay News) -- Being poorer and having co-existing health problems are among the reasons why black colorectal cancer patients have lower survival rates than whites or Asians in the United States, new study findings suggest.
Pubished :Fri, 16 Jul 2010 21:03:27 GMT
HealthDay - FRIDAY, July 16 (HealthDay News) -- Being poorer and having co-existing health problems are among the reasons why black colorectal cancer patients have lower survival rates than whites or Asians in the United States, new study findings suggest.
Pubished :Fri, 16 Jul 2010 21:03:27 GMT
FDA staff question Roche drug breast cancer data
(Reuters)
Reuters - Two studies of Roche AG's blockbuster drug Avastin failed to show the same level of benefit for advanced breast cancer patients seen in an earlier trial, U.S. reviewers said in documents released on Friday.
Pubished :Fri, 16 Jul 2010 12:04:06 GMT
Reuters - Two studies of Roche AG's blockbuster drug Avastin failed to show the same level of benefit for advanced breast cancer patients seen in an earlier trial, U.S. reviewers said in documents released on Friday.
Pubished :Fri, 16 Jul 2010 12:04:06 GMT
U.S. probing cancer risk of blood pressure drugs
(Reuters)
Reuters - U.S. health officials are investigating if a class of commonly used blood pressure drugs may increase cancer risk after a recent study raised concern.
Pubished :Thu, 15 Jul 2010 21:27:15 GMT
Reuters - U.S. health officials are investigating if a class of commonly used blood pressure drugs may increase cancer risk after a recent study raised concern.
Pubished :Thu, 15 Jul 2010 21:27:15 GMT
U.S. groups target 20 possible causes of cancer
(Reuters)
Reuters - The American Cancer Society and three federal agencies named 19 chemicals and shift work on Thursday as potential causes of cancer that deserve more investigation.
Pubished :Thu, 15 Jul 2010 18:55:17 GMT
Reuters - The American Cancer Society and three federal agencies named 19 chemicals and shift work on Thursday as potential causes of cancer that deserve more investigation.
Pubished :Thu, 15 Jul 2010 18:55:17 GMT
Study links Vatican Radio's waves to cancer risk: report
(AFP)
AFP - A court-ordered study has found that electromagnetic waves beamed by Vatican Radio leave residents living near the station's antennas at a higher risk of cancer, Italian media said Wednesday.
Pubished :Wed, 14 Jul 2010 18:10:15 GMT
AFP - A court-ordered study has found that electromagnetic waves beamed by Vatican Radio leave residents living near the station's antennas at a higher risk of cancer, Italian media said Wednesday.
Pubished :Wed, 14 Jul 2010 18:10:15 GMT
Cancer survivors have higher death risk for decades
(Reuters)
Reuters - People who survive cancer in childhood have a heightened risk of dying of a heart attack, stroke or another cancer decades later -- a risk that is likely to be due to the original treatment, scientists said on Tuesday.
Pubished :Tue, 13 Jul 2010 21:12:45 GMT
Reuters - People who survive cancer in childhood have a heightened risk of dying of a heart attack, stroke or another cancer decades later -- a risk that is likely to be due to the original treatment, scientists said on Tuesday.
Pubished :Tue, 13 Jul 2010 21:12:45 GMT
Intervention May Help Relieve Cancer Patients' Pain,
Depression
(HealthDay)
HealthDay - TUESDAY, July 13 (HealthDay News) -- Cancer patients' ability to cope with pain and depression was improved through a program that included home-based automated symptom monitoring and telephone-based care management, a new study has found.
Pubished :Tue, 13 Jul 2010 21:03:29 GMT
HealthDay - TUESDAY, July 13 (HealthDay News) -- Cancer patients' ability to cope with pain and depression was improved through a program that included home-based automated symptom monitoring and telephone-based care management, a new study has found.
Pubished :Tue, 13 Jul 2010 21:03:29 GMT
© -2008 DataSoftSystem.com